Michael Gilman is a Principal Engineer at Moderna, specializing in Global MS&T since May 2023. Prior to this role, Michael served as Associate Principal Engineer in Process Development at Verve Therapeutics from March 2022 to May 2023 and held various engineering positions at Moderna from June 2016 to March 2022, focusing on Manufacturing Science and Technology and mRNA Process Development. Earlier experience includes Clinical Manufacturing Associate roles at Alexion Pharmaceuticals, Inc. and a position as Manufacturing Process Engineer at Ercon Inc. Michael holds a Master of Science in Bioengineering with a focus on Cell and Bioprocess Engineering from Tufts University, as well as a Bachelor's degree in Chemical Engineering from the University of New Hampshire and a Certificate in Biotechnology Engineering from Tufts University.
This person is not in any teams
This person is not in any offices